A detailed history of Fmr LLC transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Fmr LLC holds 25,902 shares of MDXG stock, worth $173,802. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,902
Previous 5,928 336.94%
Holding current value
$173,802
Previous $45,000 251.11%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$5.88 - $7.69 $117,447 - $153,600
19,974 Added 336.94%
25,902 $158,000
Q1 2025

May 12, 2025

SELL
$7.54 - $9.28 $8,452 - $10,402
-1,121 Reduced 15.9%
5,928 $45,000
Q4 2024

Feb 13, 2025

SELL
$5.51 - $9.75 $257,978 - $456,495
-46,820 Reduced 86.91%
7,049 $67,000
Q3 2024

Nov 13, 2024

BUY
$5.65 - $7.76 $69,896 - $95,998
12,371 Added 29.81%
53,869 $318,000
Q2 2024

Aug 13, 2024

BUY
$6.16 - $8.08 $8,457 - $11,093
1,373 Added 3.42%
41,498 $287,000
Q1 2024

May 13, 2024

SELL
$7.61 - $8.63 $317,314 - $359,845
-41,697 Reduced 50.96%
40,125 $308,000
Q4 2023

Feb 13, 2024

SELL
$5.7 - $9.14 $159,873 - $256,358
-28,048 Reduced 25.53%
81,822 $717,000
Q3 2023

Nov 13, 2023

BUY
$6.35 - $8.16 $31,934 - $41,036
5,029 Added 4.8%
109,870 $800,000
Q2 2023

Aug 11, 2023

BUY
$3.14 - $6.61 $135,779 - $285,829
43,242 Added 70.2%
104,841 $692,000
Q1 2023

May 11, 2023

BUY
$2.97 - $4.81 $13,002 - $21,058
4,378 Added 7.65%
61,599 $210,000
Q4 2022

Feb 13, 2023

SELL
$2.63 - $3.45 $16,963 - $22,252
-6,450 Reduced 10.13%
57,221 $159,000
Q3 2022

Nov 10, 2022

SELL
$2.71 - $4.22 $40,522 - $63,101
-14,953 Reduced 19.02%
63,671 $183,000
Q2 2022

Aug 12, 2022

BUY
$3.17 - $5.0 $35,161 - $55,460
11,092 Added 16.42%
78,624 $273,000
Q1 2022

May 13, 2022

BUY
$4.27 - $6.27 $288,361 - $423,425
67,532 New
67,532 $318,000

Others Institutions Holding MDXG

About MIMEDX GROUP, INC.


  • Ticker MDXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 113,609,000
  • Market Cap $762M
  • Description
  • MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...
More about MDXG
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.